These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28597700)

  • 41. Mucoadhesive in situ forming gel for oral mucositis pain control.
    Li T; Bao Q; Shen J; Lalla RV; Burgess DJ
    Int J Pharm; 2020 Apr; 580():119238. PubMed ID: 32194210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploitation of Design-of-Experiment Approach for Design and Optimization of Fast-Disintegrating Tablets for Sublingual Delivery of Sildenafil Citrate with Enhanced Bioavailability Using Fluid-Bed Granulation Technique.
    AlAli AS; Aldawsari MF; Alalaiwe A; Almutairy BK; Al-Shdefat R; Walbi IA; Fayed MH
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fast-dissolving sublingual films of terbutaline sulfate: formulation and in vitro/in vivo evaluation.
    Sayed S; Ibrahim HK; Mohamed MI; El-Milligi MF
    Mol Pharm; 2013 Aug; 10(8):2942-7. PubMed ID: 23883311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
    Rana P; Murthy RS
    Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of Simvastatin ex vivo Permeation from Mucoadhesive Buccal Films Loaded with Dual Drug Release Carriers.
    Ahmed TA; Bawazir AO; Alharbi WS; Safo MK
    Int J Nanomedicine; 2020; 15():4001-4020. PubMed ID: 32606661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formulation and Characterization of Fast-Dissolving Sublingual Film of Iloperidone Using Box-Behnken Design for Enhancement of Oral Bioavailability.
    Londhe V; Shirsat R
    AAPS PharmSciTech; 2018 Apr; 19(3):1392-1400. PubMed ID: 29396734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell.
    Sivaraman A; Banga AK
    J Pharm Pharmacol; 2016 Jan; 68(1):26-35. PubMed ID: 26714423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and in vitro/in vivo evaluation of dihydroergotamine mesylate loaded maltodextrin-pullulan sublingual films.
    Esim O; Ozkan CK; Kurbanoglu S; Arslan A; Tas C; Savaser A; Ozkan SA; Ozkan Y
    Drug Dev Ind Pharm; 2019 Jun; 45(6):914-921. PubMed ID: 30714426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A smart approach to enable preclinical studies in pharmaceutical industry: PLGA-based extended release formulation platform for subcutaneous applications.
    Strack P; Külzer R; Sommer F; Bretschneider T; Merkel OM; Grube A
    Drug Dev Ind Pharm; 2020 Apr; 46(4):635-645. PubMed ID: 32163304
    [No Abstract]   [Full Text] [Related]  

  • 51. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
    Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA
    Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics.
    Arregui JR; Kovvasu SP; Betageri GV
    AAPS PharmSciTech; 2018 May; 19(4):1802-1809. PubMed ID: 29616488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of a novel polymer, the in-situ gelling mucoadhesive thiolated poly(aspartic acid) in ophthalmic drug delivery].
    Horvát G; Budai-Szűcs M; Berkó S; Szabóné-Révész P; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csányi Erzsébet
    Acta Pharm Hung; 2015; 85(4):115-21. PubMed ID: 26964399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
    Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
    Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, Development and In vitro/Ex vivo Evaluation of Mucoadhesive Buccal Film of Benzydamine Hydrochloride for the Effective Treatment of Aphthous Stomatitis.
    Sharma D; Sharma A; Garg R
    Recent Pat Drug Deliv Formul; 2018; 12(4):277-294. PubMed ID: 30706830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from
    Canonica GW; Devillier P; Casale T; Demoly P; Bos C; Karagiannis E; Passalacqua G; Wahn U; Mascarell L
    Expert Rev Clin Immunol; 2019 Sep; 15(9):921-928. PubMed ID: 31403823
    [No Abstract]   [Full Text] [Related]  

  • 58. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
    Amin MK; Boateng JS
    Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
    [No Abstract]   [Full Text] [Related]  

  • 59. Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 3(2) full factorial design.
    Boldhane SP; Kuchekar BS
    Curr Drug Deliv; 2009 Oct; 6(5):477-85. PubMed ID: 19863493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and optimization of a sublingual tablet formulation for physostigmine salicylate.
    Bolourchian N; Hadidi N; Foroutan SM; Shafaghi B
    Acta Pharm; 2009 Sep; 59(3):301-12. PubMed ID: 19819826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.